The contradictory effects of Epac in different cancer types and among different cell lines of the same cancer type demand focusing on downstream effectors that mediate Epac signaling to facilitate the development of new therapeutic strategies in cancer treatment. The gene discussed is RAPGEF4; the disease is cancer.